Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does pioglitazone reduce carotid intima–media thickness in patients with type 2 diabetes mellitus?

Nature Clinical Practice Endocrinology & Metabolism volume 3, pages 394–395 (2007)Cite this article

boxed-textMazzone T et al. (2006) Effect of pioglitazone compared with glimepiride on carotid intima–media thickness in type 2 diabetes: a randomized trial. JAMA 296: 2572–2581

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fonseca V et al. (2004) Non-traditional risk factors for cardiovascular disease in diabetes. Endocr Rev 25: 153–175

    Article  CAS  Google Scholar 

  2. Blaschke F et al. (2006) Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am 35: 561–574

    Article  CAS  Google Scholar 

  3. Dormandy JA et al. (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366: 1279–1289

    Article  CAS  Google Scholar 

  4. DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368: 1096–1105

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Section of Diabetes, Endocrinology and Metabolism, 983020 University of Nebraska Medical Center, Omaha, NE 68198-3020, USA cdesouza@unmc.edu

Authors and Affiliations

  1. C Desouza is an Assistant Professor in the Section of Diabetes, Endocrinology and Metabolism, University of Nebraska Medical Center, Omaha, NE, USA.,

    Cyrus Desouza

Authors
  1. Cyrus Desouza
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author has received research materials from Takeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Desouza, C. Does pioglitazone reduce carotid intima–media thickness in patients with type 2 diabetes mellitus?. Nat Rev Endocrinol 3, 394–395 (2007). https://doi.org/10.1038/ncpendmet0482

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0482

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing